Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study

Qun Wang(Wuhan University), Yan Li(Wuhan University)
Journal of Translational Medicine
August 21, 2013
Cited by 31


Related Papers